MH
Mark Haas
Cedars-Sinai Medical Center
Research areas: Medicine · Nephrology · Renal Diseases and Glomerulopathies · Renal Transplantation Outcomes and Treatments · Vasculitis and related conditions
Employment
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (18)
- Microvascular inflammation in kidney transplants: finally an effective treatment? Save
- The Oxford Classification Should Remain the Gold Standard for Classification of IgA Nephropathy: Commentary Save
- IgA Nephropathy across the Age Spectrum Save
- The Banff 2024 Kidney Meeting Report: Rejection as a spectrum of phenotypes and focus on differential diagnostic reasoning Save
- Kidney injury and colocalization of complement C3, IgA, and IgG in glomerular immune-complex deposits of patients with IgA nephropathy or IgA vasculitis with nephritis Save
- Seeing the light (chains): a paradigm shift in PGNMID Save
- IPNA recommendations for treatment of IgA nephropathy: why there should be a greater emphasis on pathology moving forward Save
- De Novo Exostosin-Associated Membranous Nephropathy in Kidney Transplant Save
- IgA nephropathy: Correlation between pathologic findings and complement activation Save
- Spectrum of Kidney Biopsy Findings Associated With Methamphetamine Use Save
- Podocyte injury as a potential therapeutic target in IgA nephropathy: should pathology guide us? Save
- Apolipoprotein E is enriched in dense deposits and is a marker for dense deposit disease in C3 glomerulopathy Save
- The Banff 2022 Kidney Meeting Report: Reappraisal of microvascular inflammation and the role of biopsy-based transcript diagnostics Save
- The Banff 2022 Kidney Meeting Work Plan: Data-driven refinement of the Banff Classification for renal allografts Save
- Improving frozen section evaluation of procurement donor kidney biopsies and reducing the discard rate: a promising role for artificial intelligence Save
- Finding the right context of use for molecular transplant diagnostics in kidney allograft biopsies Save
- Clazakizumab for desensitization in highly sensitized patients awaiting transplantation Save
- Thirty years of the International Banff Classification for Allograft Pathology: the past, present, and future of kidney transplant diagnostics Save